companydata.dkAVILEX PHARMA ApS: Financial statements 2017
CVR: 34896828
AVILEX PHARMA ApS (CVR 34896828) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -2,415,685 compared with DKK -5,450,675 the year before. Equity amounted to DKK -8,145,579. The company had 1 employee in the financial year.
- Profit/Loss
- -2,415,685 kr.
- Equity
- -8,145,579 kr.
- Total Assets
- 7,252,517 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -2.4 mio. | -8.1 mio. | 1 |
| 2016 | - | - | -5.5 mio. | -5.7 mio. | 1 |
| 2015 | - | - | -7.6 mio. | -279 t. | 3 |
| 2014 | - | - | -1.2 mio. | -4.1 mio. | 0 |
| 2013 | - | - | -2.9 mio. | -2.9 mio. | - |
Find more companies like AVILEX PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2017
AVILEX PHARMA ApS has published its annual report for 2016. The net result was DKK -5,450,675.
About AVILEX PHARMA ApS
AVILEX PHARMA ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2012. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Kristian Strømgaard. The company's owners include Novo Holdings A/S, MIKAEL SØNDERGÅRD THOMSEN ApS and KRISTIAN STRØMGAARD HOLDING ApS. The company has 3 employees. In 2024, the company reported a net result of DKK -4,428,000 compared with DKK -6,756,000 the year before. Equity amounted to DKK -6,267,000.